Tetrahedral DNA nanostructures for effective treatment of cancer: advances and prospects
Open Access
- 7 December 2021
- journal article
- review article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 19 (1) , 1-16
Abstract
Recently, DNA nanostructures with vast application potential in the field of biomedicine, especially in drug delivery. Among these, tetrahedral DNA nanostructures (TDN) have attracted interest worldwide due to their high stability, excellent biocompatibility, and simplicity of modification. TDN could be synthesized easily and reproducibly to serve as carriers for, chemotherapeutic drugs, nucleic acid drugs and imaging probes. Therefore, their applications include, but are not restricted to, drug delivery, molecular diagnostics, and biological imaging. In this review, we summarize the methods of functional modification and application of TDN in cancer treatment. Also, we discuss the pressing questions that should be targeted to increase the applicability of TDN in the future.Graphical AbstractKeywords
Funding Information
- Excellent Young Scientists Fund (51803098)
- Postdoctoral Research Foundation of China (2021TQ0160)
This publication has 117 references indexed in Scilit:
- Purification of DNA-origami nanostructures by rate-zonal centrifugationNucleic Acids Research, 2012
- DNA Self‐Assembly of Targeted Near‐Infrared‐Responsive Gold Nanoparticles for Cancer Thermo‐ChemotherapyAngewandte Chemie International Edition, 2012
- Gold nanoparticles as novel agents for cancer therapyBritish Journal of Radiology, 2012
- Site‐Specific Attachment of Proteins onto a 3D DNA Tetrahedron through Backbone‐Modified Phosphorothioate DNASmall, 2011
- A New Paradigm for Aptamer Therapeutic AS1411 Action: Uptake by Macropinocytosis and Its Stimulation by a Nucleolin-Dependent MechanismCancer Research, 2010
- A DNA Nanostructure‐based Biomolecular Probe Carrier Platform for Electrochemical BiosensingAdvanced Materials, 2010
- The effect of particle design on cellular internalization pathwaysProceedings of the National Academy of Sciences, 2008
- The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer CellsCancer Research, 2008
- Ligand-induced conformational changes allosterically activate Toll-like receptor 9Nature Immunology, 2007
- Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and CardiotoxicityPharmacological Reviews, 2004